Elevated expression of PVT1-214 is significantly associated with clinicopathological characteristics and poor survival of GC patients, and induces tumorigenic ability of GC by increasing TrkC expression via inhibition of miR-128 [37]. The gene discussed is PVT1; the disease is gastric cancer.